NCT07226843 2026-04-17
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Eli Lilly and Company
Phase 1 Not yet recruiting
Clinical Trials
9 trialsNCT07519772 2026-04-09
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Merck Sharp & Dohme LLC
Phase 1/2 Not yet recruiting
NCT07518329 2026-04-08
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Arovella Therapeutics Ltd
Phase 1 Not yet recruiting
NCT07101328 2026-03-20
BAF_FRontier-1
Eli Lilly and Company
Phase 1 Not yet recruiting
NCT07454863 2026-03-06
A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)
Dizal Pharmaceuticals
Phase 1 Not yet recruiting
NCT07003178 2025-06-04
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
Starna Therapeutics
Phase EARLY_PHASE1 Not yet recruiting
NCT06845241 2025-02-25
Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06318884 2024-03-22
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
Sinocelltech Ltd.
Phase 1 Not yet recruiting
NCT05381181 2023-01-27
Safety and Efficacy Evaluation of Next-generation CD19-UCART
Bioray Laboratories
Phase 1 Not yet recruiting